T. Rowe Price Health Sciences Portfolio

T. Rowe Price Health Sciences Portfolio reported 187 holdings worth US$752M as of Jun 30, 2026 (Form N-PORT)

As of Jun 30, 2026 · Filed Aug 27, 2026

T. Rowe Price Health Sciences Portfolio reported 187 holdings worth US$752M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. Filed Aug 27, 2026 (Form N-PORT).

Holdings
187
Value as reported
US$752M

The filing in full

CompanySharesValue as reported% of portfolio
Eli Lilly And Company88,118US$106M14.1%
Johnson & Johnson196KUS$49.9M6.6%
Unitedhealth Group Incorporated106KUS$44.2M5.9%
Abbvie Inc.153KUS$38.5M5.1%
Merck & Company, Inc.234KUS$30M4.0%
Gilead Sciences, Inc.166KUS$21M2.8%
Thermo Fisher Scientific Inc37,982US$19M2.5%
Vertex Pharmaceuticals Incorporated34,183US$17M2.3%
Bristol-myers Squibb Company276KUS$15.9M2.1%
Abbott Laboratories159KUS$14.4M1.9%
Intuitive Surgical, Inc.35,632US$14.2M1.9%
Amgen Inc.37,413US$13.5M1.8%
Stryker Corporation42,615US$13.4M1.8%
Elevance Health, Inc.30,021US$11.6M1.5%
Danaher Corporation56,740US$10.8M1.4%
Natera, Inc.39,765US$10.8M1.4%
Guardant Health, Inc.61,138US$9.17M1.2%
Cardinal Health, Inc.32,906US$7.82M1.0%
Royalty Pharma Plc130KUS$7.29M0.97%
Tenet Healthcare Corporation37,832US$7.08M0.94%
Cvs Health Corporation67,598US$6.99M0.93%
Kymera Therapeutics, Inc.58,378US$6.69M0.89%
Protagonist Therapeutics, Inc.52,256US$6.41M0.85%
Moderna, Inc.89,300US$6.25M0.83%
Revolution Medicines, Inc.32,711US$6.13M0.81%
Brightspring Health Services, Inc.87,705US$6.12M0.81%
Roivant Sciences Ltd.157KUS$5.56M0.74%
Alnylam Pharmaceuticals, Inc.17,554US$5.28M0.70%
Viatris Inc.313KUS$4.97M0.66%
Charles River Laboratories International, Inc.20,331US$4.61M0.61%
Argenx Se4,836US$4.49M0.60%
Edwards Lifesciences Corporation48,999US$4.43M0.59%
Centene Corporation67,827US$4.35M0.58%
Spyre Therapeutics, Inc.47,651US$4.23M0.56%
Definium Therapeutics, Inc.81,159US$3.82M0.51%
Insmed Incorporated34,665US$3.7M0.49%
Chugai Pharmaceutical Co., Ltd.78,800US$3.64M0.48%
Astrazeneca Plc18,933US$3.59M0.48%
Twist Bioscience Corporation34,800US$3.58M0.48%
Boston Scientific Corporation80,431US$3.43M0.46%
Medtronic Plc.42,600US$3.33M0.44%
United Therapeutics Corporation6,122US$3.32M0.44%
Krystal Biotech, Inc.8,820US$3.28M0.44%
Erasca, Inc.163KUS$2.99M0.40%
Billiontoone, Inc.24,722US$2.97M0.39%
Medpace Holdings, Inc.5,452US$2.89M0.38%
Ascendis Pharma A/s10,794US$2.88M0.38%
Praxis Precision Medicines, Inc.8,505US$2.85M0.38%
Scholar Rock Holding Corporation51,768US$2.85M0.38%
Beone Medicines Ltd. Class A10,300US$2.84M0.38%
Tango Therapeutics, Inc.88,611US$2.77M0.37%
Oruka Therapeutics, Inc.28,926US$2.75M0.37%
Monte Rosa Therapeutics, Inc.113KUS$2.73M0.36%
Dianthus Therapeutics, Inc.27,805US$2.71M0.36%
Humana Inc.6,700US$2.66M0.35%
Kodiak Sciences Inc64,006US$2.49M0.33%
Axsome Therapeutics, Inc.9,806US$2.4M0.32%
Relay Therapeutics, Inc.125KUS$2.34M0.31%
Summit Therapeutics Inc.159KUS$2.31M0.31%
Cg Oncology, Inc.32,546US$2.31M0.31%
Novo Nordisk A/s Class B47,838US$2.26M0.30%
Cytokinetics, Incorporated26,225US$2.23M0.30%
Vera Therapeutics, Inc.50,781US$2.18M0.29%
Regeneron Pharmaceuticals, Inc.3,492US$2.18M0.29%
Ionis Pharmaceuticals, Inc.27,443US$2.18M0.29%
Mbx Biosciences, Inc.38,917US$2.15M0.29%
Agilent Technologies, Inc.15,700US$2.09M0.28%
Enliven Therapeutics, Inc.40,438US$2.05M0.27%
Crinetics Pharmaceuticals, Inc.53,507US$2M0.27%
Mirum Pharmaceuticals, Inc.17,030US$1.99M0.27%
Bridgebio Pharma, Inc.26,489US$1.97M0.26%
Madrigal Pharmaceuticals, Inc.3,670US$1.97M0.26%
Newamsterdam Pharma Company N.v.57,600US$1.95M0.26%
Waters Corporation5,200US$1.95M0.26%
Nurix Therapeutics, Inc.79,238US$1.92M0.26%
Beam Therapeutics Inc.55,798US$1.91M0.25%
Liquidia Corporation22,754US$1.81M0.24%
Rhythm Pharmaceuticals, Inc.15,935US$1.77M0.24%
West Pharmaceutical Services, Inc.4,795US$1.72M0.23%
Ideaya Biosciences, Inc.45,571US$1.7M0.23%
Teva Pharmaceutical Industries Limited49,500US$1.68M0.22%
Viridian Therapeutics, Inc.91,287US$1.68M0.22%
Alkermes Plc31,800US$1.67M0.22%
Immunome, Inc.78,194US$1.66M0.22%
Alignment Healthcare, Inc.69,056US$1.64M0.22%
Rapport Therapeutics, Inc.38,093US$1.59M0.21%
Vaxcyte, Inc.26,234US$1.52M0.20%
Palvella Therapeutics, Inc.9,807US$1.5M0.20%
Climb Bio, Inc.103KUS$1.34M0.18%
Icon Plc7,500US$1.3M0.17%
Celldex Therapeutics, Inc.33,464US$1.25M0.17%
Kailera Therapeutics, Inc.55,664US$1.23M0.16%
Bicara Therapeutics Inc.41,165US$1.22M0.16%
Oric Pharmaceuticals, Inc.107KUS$1.16M0.15%
Encompass Health Corporation10,970US$1.11M0.15%
Moonlake Immunotherapeutics55,515US$1.08M0.14%
Cencora, Inc.3,786US$1.07M0.14%
Alumis Inc.37,626US$1.06M0.14%
Abivax Sa7,941US$1.06M0.14%
Apogee Therapeutics, Inc.7,943US$1.05M0.14%

Every holding of T. Rowe Price Health Sciences Portfolio

Source

View original at SEC

Related